The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.
Alexa R. Hospodar, BS
Advertisement
Articles by Alexa R. Hospodar, BS
Advertisement
Latest Updated Articles
- Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?
Published: February 15th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC
2
FDA Approves Ruxolitinib Cream for Patients as Young as 2 Years With Atopic Dermatitis
3
Pirtobrutinib Shows Clinically Meaningful PFS Improvement in Frontline CLL
4
AHA Launches New Initiative to Help Patients With Heart Failure
5
